Video: What’s Next for Clinical Research?

The CF Foundation is focused on bringing forward new therapies to help people with CF enjoy the best health and quality of life. 

| 1 min read
Christina-Roman
Christina Roman
Mike Boyle_Rectangle

Following the approval of the new CF drug Orkambi, we sat down with Dr. Mike Boyle, our new vice president of therapeutics development, to learn more about the future of clinical research and what's most exciting.

This site contains general information about cystic fibrosis, as well as personal insight from the CF community. Opinions and experiences shared by members of our community, including but not limited to people with CF and their families, belong solely to the blog post author and do not represent those of the Cystic Fibrosis Foundation, unless explicitly stated. In addition, the site is not intended as a substitute for treatment advice from a medical professional. Consult your doctor before making any changes to your treatment.

Share this article
Topics
CFTR Modulators | Clinical Trials
Christina-Roman

As community engagement manager for the Cystic Fibrosis Foundation, Christina works to help embed the voice of the community into the work of the Foundation. Before joining the community partnerships team Christina worked on the clinical trials team for 3 years and at Colorado Children's Hospital for 2 years supporting the CF team. She holds a master's degree in public health from the University of Colorado. Originally from Estes Park, Colo., Christina now lives in Washington, D.C., with her husband.

Recent Community Posts
A Letter to Myself
Blog | 6 min read
People With CF Are Living Longer. What Does That Mean for Our Care?
Blog | 6 min read
How I Felt Seeing My Daughter in Her Vest for the First Time
Blog | 3 min read